Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391807 · ClinicalTrials.gov registry record · Phase 3
Study of Safety and Efficacy of an Oral Contraceptive
A Phase 3 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,683
- Enrollment target
NCT00391807: Completed Phase 3 study, sponsored by Warner Chilcott.
NCT00391807 is a Phase 3 study that has completed, run by Warner Chilcott. The registered enrollment target is 1,683 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (118% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00391807, a Phase 3 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,683 participants
- Enrollment target
Study Summary
This is a non-comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.
Interventions
- DRUG Norethindrone acetate/ethinyl estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,683 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
What the finished NCT00391807 record still lists
NCT00391807 is an interventional study that assigns participants to a tested intervention. Its 1,683 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (118% higher).
The record links to 0 conditions, and to 1 intervention - of which Norethindrone acetate/ethinyl estradiol is the first listed.
NCT00391807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00391807 about?
NCT00391807 is a clinical study titled "Study of Safety and Efficacy of an Oral Contraceptive". This is a non-comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.
What is the current status of trial NCT00391807?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,683 participants. The study started on 2006-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00391807?
The interventions under investigation include: Norethindrone acetate/ethinyl estradiol (DRUG).
Who is sponsoring clinical trial NCT00391807?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00391807's enrollment target sits among peer trials
1,683 134th of 2000 higher than 1,866 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia